2018 Earnings Spotlight: Stryker And Nuvasive Lead The Ortho Pack In 2018
Reported sales and earnings from the big publicly traded orthopedics device companies showed mostly slow growth in 2018, but NuVasive and Stryker reported high single-digit growth while, Smith & Nephew grew in the low single-digits, fueling reports that Smith & Nephew may try to buy NuVasive.
You may also be interested in...
Stryker Goes Shoulder To Shoulder With Wright Medical In $4Bn Takeover
Stryker is acquiring rival Wright Medical in a $4bn deal catapulting the company to a top position in the trauma and extremities market. The agreement, announced on 4 November, is Stryker’s biggest acquisition this year.
NASS2019: Robotics Spotlight Is On New Platforms By Globus Medical, NuVasive
Robotic systems took center stage at this year's annual spine society meeting in Chicago. NuVasive unveiled its new Pulse robotic spine surgery system with several differentiating features. Globus Medical showcased a new imaging platform and Interbody module.
Mako Robot Sales Drive Stryker’s Orthopedics Business In Second Quarter
Stryker reported organic growth of 8.5% during the second quarter of 2019 led by 12% growth in the medical and surgical equipment business, 7% growth in neurotechnology and spine revenue, and 6% growth in sales of orthopedic devices, led by the Mako robotic surgery system.